Icovamenib

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameIcovamenib
Drug Alias NameCovalent menin inhibitor(Biomea Fusion)BMF-219
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin inhibitors
TargetsMenin
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Carcinoma, Non-Small-Cell Lung +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomea Fusion Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomea Fusion Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes Mellitus, Type 1Carcinoma, Non-Small-Cell LungPancreatic Neoplasms +[14] 

Other Information

ATC CodeN/A
Related LinksN/A